Page 48 - MI-2-1

Microbes & Immunity iPSC-derived NK cell immunotherapy

mobilization. Oncotarget. 2017;8(19):31876-31887. transcription in chronic HBV-infected patients.
Immunobiology. 2022;227(6):152272.
doi: 10.18632/oncotarget.16311
doi: 10.1016/j.imbio.2022.152272
62. Memmer S, Weil S, Beyer S, et al. The stalk domain of
NKp30 contributes to ligand binding and signaling of 72. Cadoux M, Caruso S, Pham S, et al. Expression of
a preassembled NKp30-CD3ζ complex. J Biol Chem. NKG2D ligands is downregulated by β-catenin signalling
2016;291(49):25427-25438. and associates with HCC aggressiveness. J Hepatol.
2021;74(6):1386-1397.
doi: 10.1074/jbc.M116.742981
doi: 10.1016/j.jhep.2021.01.017
63. Fauriat C, Just-Landi S, Mallet F, et al. Deficient expression
of NCR in NK cells from acute myeloid leukemia: Evolution 73. Chu PS, Nakamoto N, Taniki N, et al. On-treatment decrease
during leukemia treatment and impact of leukemia cells in of NKG2D correlates to early emergence of clinically evident
NCRdull phenotype induction. Blood. 2007;109(1):323-330. hepatocellular carcinoma after interferon-free therapy for
chronic hepatitis C. PLoS One. 2017;12(6):e0179096.
doi: 10.1182/blood-2005-08-027979
doi: 10.1371/journal.pone.0179096
64. Wang W, Guo H, Geng J, et al. Tumor-released Galectin-3,
a soluble inhibitory ligand of human NKp30, plays an 74. Sha WH, Zeng XH, Min L. The correlation between NK cell
important role in tumor escape from NK cell attack. J Biol and liver function in patients with primary hepatocellular
Chem. 2014;289(48):33311-33319. carcinoma. Gut Liver. 2014;8(3):298-305.
doi: 10.1074/jbc.M114.603464 doi: 10.5009/gnl.2014.8.3.298
65. Nieto-Velázquez NG, Torres-Ramos YD, Muñoz- 75. Fang X, Guo L, Xing Z, et al. IDO1 can impair NK
Sánchez JL, et al. Altered expression of natural cytotoxicity cells function against non-small cell lung cancer by
receptors and NKG2D on peripheral blood NK Cell subsets downregulation of NKG2D Ligand via ADAM10. Pharmacol
in breast cancer patients. Transl Oncol. 2016;9(5):384-391. Res. 2022;177:106132.
doi: 10.1016/j.tranon.2016.07.003 doi: 10.1016/j.phrs.2022.106132
66. Krijgsman D, Roelands J, Andersen MN, et al. Expression of 76. Schilling D, Tetzlaff F, Konrad S, Li W, Multhoff G.
NK cell receptor ligands in primary colorectal cancer tissue A hypoxia-induced decrease of either MICA/B or Hsp70 on
in relation to the phenotype of circulating NK- and NKT the membrane of tumor cells mediates immune escape from
cells, and clinical outcome. Mol Immunol. 2020;128:205-218. NK cells. Cell Stress Chaperones. 2015;20(1):139-147.
doi: 10.1016/j.molimm.2020.10.012 doi: 10.1007/s12192-014-0532-5
67. Binici J, Hartmann J, Herrmann J, et al. A soluble fragment of 77. Ou ZL, Luo Z, Wei W, Liang S, Gao TL, Lu YB. Hypoxia-induced
the tumor antigen BCL2-associated athanogene 6 (BAG-6) shedding of MICA and HIF1A-mediated immune escape of
is essential and sufficient for inhibition of NKp30 receptor- pancreatic cancer cells from NK cells: Role of circ_0000977/
dependent cytotoxicity of natural killer cells. J Biol Chem. miR-153 axis. RNA Biol. 2019;16(11):1592-1603.
2013;288(48):34295-34303.
doi: 10.1080/15476286.2019.1649585
doi: 10.1074/jbc.M113.483602
78. Garrido F, Algarra I, Garcia-Lora AM. The escape of cancer
68. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, from T lymphocytes: Immunoselection of MHC class I loss
Carlyle JR, Raulet DH. The role of the NKG2D variants harboring structural-irreversible “hard” lesions.
immunoreceptor in immune cell activation and natural Cancer Immunol Immunother. 2010;59(10):1601-1606.
killing. Immunity. 2002;17(1):19-29.
doi: 10.1007/s00262-010-0893-2
doi: 10.1016/s1074-7613(02)00333-3
79. Derre L, Corvaisier M, Charreau B, et al. Expression and
69. Wu J, Song Y, Bakker AB, et al. An activating release of HLA-E by melanoma cells and melanocytes:
immunoreceptor complex formed by NKG2D and DAP10. Potential impact on the response of cytotoxic effector cells.
Science. 1999;285(5428):730-732. J Immunol. 2006;177(5):3100-3107.
doi: 10.1126/science.285.5428.730 doi: 10.4049/jimmunol.177.5.3100
70. Lee MJ, Leong MW, Rustagi A, et al. SARS-CoV-2 escapes 80. Paul P, Rouas-Freiss N, Khalil-Daher I, et al. HLA-G
direct NK cell killing through Nsp1-mediated downregulation expression in melanoma: A way for tumor cells to escape
of ligands for NKG2D. Cell Rep. 2022;41(13):111892. from immunosurveillance. Proc Natl Acad Sci U S A.
1998;95(8):4510-4515.
doi: 10.1016/j.celrep.2022.111892
doi: 10.1073/pnas.95.8.4510
71. Huang X, Mo Q, Fu T, Liu Y, Diao B. STAT1 is associated
with NK cell dysfunction by downregulating NKG2D 81. Merino AM, Kim H, Miller JS, Cichocki F. Unraveling

Volume 2 Issue 1 (2025) 40 doi: 10.36922/mi.5653